Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis
Article in Exploration of Targeted Anti-tumor Therapy (June 2024)
The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.
Article in Exploration of Targeted Anti-tumor Therapy (June 2024)
Article in World Journal of Gastroenterology (May 2024)
Article in F1000Research (May 2024)